Inhibitors of HCV replication of formula I
including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R* have the meaning defined in the claims.
The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in the treatment or prophylaxis of HCV.
公式I的HCV复制
抑制剂包括立体
化学同分异构体形式,以及其盐、
水合物、溶剂合物,其中R和R*的含义如索赔中所定义。本发明还涉及制备这些化合物的方法、含有它们的药物组合物以及它们的使用,单独或与其他HCV
抑制剂结合,用于治疗或预防HCV。